(Q46799215)

25 December 2017

title

How FDA currently makes decisions on clinical studies (English)

1 reference

25 December 2017

author name string

Robert Temple

series ordinal

1

1 reference

25 December 2017

publication date

1 January 2005

1 reference

25 December 2017

published in

Clinical Trials

1 reference

25 December 2017

volume

2

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

276-81; discussion 364-78

1 reference

25 December 2017

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN097OA

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN097OA

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN097OA

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN097OA

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN097OA

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1740774505CN097OA

10.1191/1740774505CN097OA

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017